Christophe Dugave

3.9k total citations · 1 hit paper
60 papers, 3.2k citations indexed

About

Christophe Dugave is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Christophe Dugave has authored 60 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Organic Chemistry. Recurrent topics in Christophe Dugave's work include Peptidase Inhibition and Analysis (15 papers), Chemical Synthesis and Analysis (11 papers) and Signaling Pathways in Disease (10 papers). Christophe Dugave is often cited by papers focused on Peptidase Inhibition and Analysis (15 papers), Chemical Synthesis and Analysis (11 papers) and Signaling Pathways in Disease (10 papers). Christophe Dugave collaborates with scholars based in France, Germany and Sweden. Christophe Dugave's co-authors include Luc Demange, Martine Heyman, Nadine Cerf–Bensussan, Céline Candalh, Andre Ménèz, Christophe Cellier, Corinne Lebreton, Tamara Matysiak‐Budnik, Grégory Pieters and Bruno Chaudret and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Christophe Dugave

60 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cis−Trans Isomerization of Organic Molecules and Biomolecules: Implications and Applications

2003 875 citations Christophe Dugave, Luc Demange profile →

Peers

Countries citing papers authored by Christophe Dugave

Since Specialization

Citations

This map shows the geographic impact of Christophe Dugave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Dugave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Dugave more than expected).

Fields of papers citing papers by Christophe Dugave

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Dugave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Dugave. The network helps show where Christophe Dugave may publish in the future.

Co-authorship network of co-authors of Christophe Dugave

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Dugave. A scholar is included among the top collaborators of Christophe Dugave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Dugave. Christophe Dugave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging 2022 ·Pharmaceuticals ·(unknown), (unknown), Sébastien Goutal, (unknown), Mikhail Kondrashov, (unknown), Florent L. Besson, Christophe Dugave, Gail L. Wrigley, (unknown), Bertrand Kühnast, Magnus Schou, Nicolas Tournier, Charles S. Elmore, Fabien Caillé	2
2	NHC‐Stabilized Iridium Nanoparticles as Catalysts in Hydrogen Isotope Exchange Reactions of Anilines 2019 ·Angewandte Chemie ·Mégane Valero, Donia Bouzouita, Alberto Palazzolo, Jens Atzrodt, Christophe Dugave, Simon Tricard, Sophie Feuillastre, Grégory Pieters, Bruno Chaudret, Volker Derdau	17
3	NHC‐Stabilized Iridium Nanoparticles as Catalysts in Hydrogen Isotope Exchange Reactions of Anilines 2019 ·Angewandte Chemie International Edition ·Mégane Valero, Donia Bouzouita, Alberto Palazzolo, Jens Atzrodt, Christophe Dugave, Simon Tricard, Sophie Feuillastre, Grégory Pieters, Bruno Chaudret, Volker Derdau	67
4	Enantiospecific CH Activation Using Ruthenium Nanocatalysts 2015 ·Angewandte Chemie International Edition ·Céline Taglang, Luis M. Martínez‐Prieto, Iker Del Rosal, Laurent Maron, Romuald Poteau, Karine Philippot, Bruno Chaudret, (unknown), (unknown), Céline Puente, Christophe Dugave, Bernard Rousseau, Grégory Pieters	132
5	Enantiospecific CH Activation Using Ruthenium Nanocatalysts 2015 ·Angewandte Chemie ·Céline Taglang, Luis M. Martínez‐Prieto, Iker Del Rosal, (unknown), Romuald Poteau, Karine Philippot, Bruno Chaudret, (unknown), (unknown), Céline Puente, Christophe Dugave, Bernard Rousseau, Grégory Pieters	35
6	Understanding a Host–Guest Model System through ¹²⁹Xe NMR Spectroscopic Experiments and Theoretical Studies 2014 ·Angewandte Chemie International Edition ·Emmanuelle Dubost⧫, Jean‐Pierre Dognon, Bernard Rousseau, (unknown), Christophe Dugave, Yves Boulard, Estelle Léonce, Céline Boutin, Patrick Berthault	24
7	Regioselective and Stereospecific Deuteration of Bioactive Aza Compounds by the Use of Ruthenium Nanoparticles 2013 ·Angewandte Chemie International Edition ·Grégory Pieters, Céline Taglang, Eric Bonnefille, Torsten Gutmann, Céline Puente, J.‐C. Berthet, Christophe Dugave, Bruno Chaudret, Bernard Rousseau	149
8	Abnormal apical-to-basal transport of dietary ovalbumin by secretory IgA stimulates a mucosal Th1 response 2013 ·Mucosal Immunology ·(unknown), Corinne Lebreton, (unknown), Armelle Cuvillier, Michel Cogné, Bertrand Meresse, Christophe Dugave, Meriem Garfa‐Traoré, Blaise Corthésy, Nadine Cerf–Bensussan, Martine Heyman	7
9	Synthesis and biological evaluation of a new triazole–oxotechnetium complex 2012 ·Organic & Biomolecular Chemistry ·(unknown), Loı̈c Le Clainche, Bertrand Czarny, Christophe Dugave	6
10	Chelate oxorhenium to assemble new integrin antagonists 2011 ·Journal of Inorganic Biochemistry ·(unknown), (unknown), (unknown), Denis Servent, Christophe Dugave	3
11	Oxorhenium‐Mediated Assembly of Noncyclic Selective Integrin Antagonists: A Combinatorial Approach 2011 ·ChemBioChem ·Marie Aufort, (unknown), (unknown), Bertrand Czarny, Loı̈c Le Clainche, Robert Thaï, Christophe Dugave	5
12	Dynamic Combinatorial Self‐Assembly of Cyclophilin hCyp‐18 Ligands through Oxorhenium Coordination 2008 ·ChemBioChem ·Cécile Clavaud, (unknown), Robert Thaï, Mireille Moutiez, Christophe Dugave	8
13	Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease 2007 ·The Journal of Experimental Medicine ·Tamara Matysiak‐Budnik, Ivan Cruz Moura, Michelle Arcos‐Fajardo, Corinne Lebreton, Sandrine Ménard, Céline Candalh, (unknown), Christophe Dugave, Houda Tamouza, Guillaume van Niel, Yoram Bouhnik, Dominique Lamarque, Stanislas Chaussade, Georgia Malamut, Christophe Cellier, Nadine Cerf–Bensussan, Renato C. Monteiro, Martine Heyman	220
14	Cis-trans isomerization in biochemistry 2006 ·Wiley-VCH eBooks ·Christophe Dugave	40
15	Ontogenic and adult whole body distribution of aminopeptidase N in rat investigated by in vitro autoradiography 2004 ·Biochimie ·(unknown), (unknown), Florence Noble, Stéphane Melik Parsadaniantz, Huixiong Chen, Christophe Dugave, (unknown), William Rostène, Marie‐Claude Fournié‐Zaluski, Bernárd P. Roques, T. Popovici	27
16	Alterations of the intestinal transport and processing of gliadin peptides in celiac disease 2003 ·Gastroenterology ·Tamara Matysiak‐Budnik, Céline Candalh, Christophe Dugave, Abdelkader Namane, Christophe Cellier, Nadine Cerf–Bensussan, Martine Heyman	119
17	Synthesis and biological characterisation of [3H]BBL454, a new CCK2 selective radiolabelled agonist displaying original pharmacological properties 2003 ·Bioorganic & Medicinal Chemistry Letters ·Bruno Bellier, Christophe Dugave, (unknown), Roger Genet, Véronique Gigoux, Christiane Garbay	5
18	Interaction of human cyclophilin hCyp‐18 with short peptides suggests the existence of two functionally independent subsites 2001 ·FEBS Letters ·Luc Demange, Mireille Moutiez, (unknown), Christophe Dugave	14
19	Cellular uptake and interaction with purified membranes of rebeccamycin derivatives 2000 ·European Journal of Pharmacology ·Jean‐François Goossens, Jean‐Pierre Hénichart, Fabrice Anizon, Michelle Prudhomme, Christophe Dugave, Jean‐François Riou, Christian Bailly	4
20	Studies on the formation of 14-membered macrocycles by intramolecular Michael addition 1995 ·Christophe Crévisy, Michel Couturier, Christophe Dugave, Yves L. Dory, Pierre Deslongchamps	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact